Jon D Levine Selected Research

Jon D Levine Research Topics

Disease

103	Hyperalgesia 01/2022 - 07/2002
83	Pain (Aches) 06/2022 - 07/2002
35	Neoplasms (Cancer) 01/2023 - 01/2004
29	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2004
24	Chronic Pain 12/2018 - 12/2007
22	Neuralgia (Stump Neuralgia) 01/2022 - 01/2004
20	Fatigue 04/2022 - 06/2012
19	Breast Neoplasms (Breast Cancer) 05/2022 - 05/2012
18	Lung Neoplasms (Lung Cancer) 06/2022 - 08/2015
12	Syndrome (Syndromes) 08/2022 - 06/2012
12	Inflammation (Inflammations) 01/2021 - 05/2003
11	Myalgia 01/2021 - 05/2008
7	Nausea 05/2022 - 01/2018
7	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2022 - 02/2017
7	Acquired Immunodeficiency Syndrome (AIDS) 08/2011 - 01/2004
6	Postoperative Pain 01/2019 - 03/2003
6	Mastodynia 11/2017 - 05/2012
4	Musculoskeletal Pain 01/2021 - 04/2010
4	Fibromyalgia (Fibrositis) 01/2021 - 10/2010
4	Alcoholism (Alcohol Abuse) 11/2013 - 06/2005
4	Alcoholic Neuropathy (Alcoholic Polyneuropathy) 07/2011 - 07/2006
4	Burns 03/2008 - 12/2006
3	Vomiting 05/2022 - 01/2020
3	Hypersensitivity (Allergy) 10/2021 - 01/2004
3	Hearing Loss (Hearing Impairment) 02/2018 - 01/2018
3	Tinnitus 02/2018 - 01/2018
3	Necrosis 09/2011 - 05/2003

Drug/Important Bio-Agent (IBA)

34	OligodeoxyribonucleotidesIBA 01/2022 - 02/2004
30	Dinoprostone (PGE2)FDA Link 10/2021 - 05/2003
21	ProstaglandinsIBA 01/2022 - 10/2002
18	Opioid Analgesics (Opioids)IBA 10/2021 - 10/2002
18	CytokinesIBA 01/2018 - 03/2008
16	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 02/2004
16	Messenger RNA (mRNA)IBA 10/2021 - 07/2008
14	Protein Kinase C-epsilonIBA 01/2016 - 02/2003
13	Epinephrine (Adrenaline)FDA LinkGeneric 10/2018 - 02/2003
12	Protein Kinases (Protein Kinase)IBA 01/2016 - 05/2005
11	Analgesics (Analgesic Drugs)IBA 01/2022 - 03/2003
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 05/2008
10	Estrogens (Estrogen)FDA Link 01/2021 - 09/2003
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2003
9	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2008
9	Nerve Growth Factor (NGF)IBA 01/2018 - 06/2005
9	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2017 - 10/2002
9	CarrageenanIBA 02/2012 - 05/2003
8	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2019 - 03/2010
8	Protein Kinase CIBA 01/2019 - 10/2002
7	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 10/2018
7	Pharmaceutical PreparationsIBA 10/2019 - 06/2003
6	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 08/2002
6	Ion Channels (Ion Channel)IBA 01/2021 - 05/2004
6	LectinsIBA 01/2019 - 06/2005
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2004
6	IntegrinsIBA 01/2015 - 02/2004
6	Zalcitabine (Hivid)FDA Link 08/2011 - 01/2004
6	BradykininIBA 07/2005 - 10/2002
5	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022 - 01/2018
5	PlatinumIBA 01/2022 - 05/2008
5	GTP-Binding Proteins (G-Protein)IBA 01/2022 - 06/2011
5	AntiemeticsIBA 01/2021 - 01/2018
5	Opioid Receptors (Opioid Receptor)IBA 01/2021 - 04/2008
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019 - 09/2011
5	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 05/2018 - 03/2010
5	Narcotic Antagonists (Opioid Antagonists)IBA 01/2017 - 03/2003
5	InterleukinsIBA 01/2017 - 03/2008
5	Naloxone (Narcan)FDA LinkGeneric 01/2017 - 03/2003
5	Endothelin-1 (Endothelin 1)IBA 10/2015 - 01/2012
5	Ethanol (Ethyl Alcohol)IBA 07/2011 - 07/2006
5	Prostaglandins EIBA 09/2010 - 08/2003
5	Nalbuphine (Nubain)FDA LinkGeneric 04/2008 - 03/2003
4	Phosphotransferases (Kinase)IBA 10/2021 - 06/2005
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021 - 01/2008
4	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 03/2006
4	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2013 - 07/2008
4	Reverse Transcriptase InhibitorsIBA 09/2010 - 01/2004
4	NucleosidesIBA 09/2010 - 01/2004
3	Hyaluronan ReceptorsIBA 01/2022 - 01/2021
3	taxaneIBA 01/2022 - 01/2018
3	Protein Isoforms (Isoforms)IBA 10/2021 - 06/2005
3	CalciumIBA 10/2021 - 01/2004
3	Toll-Like Receptor 4IBA 10/2021 - 01/2019
3	CorticosteroneIBA 01/2021 - 10/2009
3	PotassiumIBA 01/2019 - 03/2014
3	LigandsIBA 11/2017 - 12/2004
3	Potassium Channels (Potassium Channel)IBA 03/2017 - 03/2014
3	Estrogen ReceptorsIBA 01/2017 - 06/2011
3	Interleukin-10 (Interleukin 10)IBA 01/2017 - 02/2014
3	EnkephalinsIBA 03/2016 - 10/2002
3	LipidsIBA 01/2015 - 05/2005
3	Adenosine Triphosphate (ATP)IBA 07/2014 - 03/2006
3	AntioxidantsIBA 08/2011 - 05/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2011 - 07/2010

Therapy/Procedure

86	Drug Therapy (Chemotherapy) 01/2023 - 05/2004
20	Therapeutics 01/2022 - 01/2004
12	Analgesia 01/2022 - 03/2003
11	Intradermal Injections 01/2016 - 02/2004
7	Spinal Injections 11/2011 - 01/2004
5	Vagotomy 10/2003 - 10/2002
4	Intramuscular Injections 03/2020 - 09/2010
3	Castration 01/2021 - 05/2003